help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, C. D.
Right arrow Articles by Lessey, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, C. D.
Right arrow Articles by Lessey, B. A.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 8 3912-3917
Copyright © 2001 by The Endocrine Society


Other Original Articles

A Prospective, Randomized Study of Endometrial Telomerase during the Menstrual Cycle

Christopher D. Williams, John F. Boggess, L. Robert LaMarque, William R. Meyer, Michael J. Murray, Marc A. Fritz and Bruce A. Lessey

Department of Obstetrics and Gynecology, Divisions of Reproductive Endocrinology and Fertility (C.D.W., L.R.L., W.R.M., M.A.F., B.A.L.) and Gynecologic Oncology (J.F.B.), University of North Carolina, Chapel Hill, North Carolina 27599; and Kaiser Permanente (M.J.M.), Sacramento, California 95815

Address all correspondence and requests for reprints to: John F. Boggess, M.D., Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of North Carolina at Chapel Hill, Campus Box 7570, Chapel Hill, North Carolina 27599-7570.

Abstract

The purpose of this study was to characterize telomerase activity during the menstrual cycle, focusing on the luteal phase. A total of 84 endometrial biopsy samples were obtained from 72 participants. Daily urinary LH testing (OvuQuick, Quidel) was used to establish the day of the LH rise, and participants were randomized to return during the secretory phase. Twelve women returned on the identical day during the luteal phase of a subsequent cycle to allow intercycle comparisons of telomerase activity. Telomerase activity was evaluated using a modified TRAP-eze (Intergen) detection protocol. At the time of each endometrial biopsy, serum estrogen and progesterone were measured. Proliferative phase endometrium showed high telomerase activity. At the onset of the luteal phase telomerase activity was high, but it decreased during the early luteal phase, disappeared by the midluteal phase (6 d after LH surge detected), and then rose to moderate levels in the late luteal phase beginning on luteal d 10. Serum progesterone levels were inversely related to telomerase activity.

In conclusion, endometrial telomerase activity is dynamic: high during the proliferative phase but inhibited during the midsecretory phase of the menstrual cycle. The timing of expression coincides with the rise and fall of progesterone levels and the time period of maximal uterine receptivity for embryo implantation. This supports a relationship between sex steroid levels and telomerase regulation.




This article has been cited by other articles:


Home page
Hum ReprodHome page
D.K. Hapangama, M.A. Turner, J.A. Drury, S. Quenby, A. Hart, M. Maddick, C. Martin-Ruiz, and T. von Zglinicki
Sustained replication in endometrium of women with endometriosis occurs without evoking a DNA damage response
Hum. Reprod., March 1, 2009; 24(3): 687 - 696.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. A. Akbay, C. M. Contreras, S. A. Perera, J. P. Sullivan, R. R. Broaddus, J. O. Schorge, R. Ashfaq, H. Saboorian, K.-K. Wong, and D. H. Castrillon
Differential Roles of Telomere Attrition in Type I and II Endometrial Carcinogenesis
Am. J. Pathol., August 1, 2008; 173(2): 536 - 544.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D.K. Hapangama, M.A. Turner, J.A. Drury, S. Quenby, G. Saretzki, C. Martin-Ruiz, and T. Von Zglinicki
Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length
Hum. Reprod., July 1, 2008; 23(7): 1511 - 1519.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C.M. Kim, Y.J. Oh, S.H. Cho, D.J. Chung, J.Y. Hwang, K.H. Park, D.J. Cho, Y.M. Choi, and B.S. Lee
Increased telomerase activity and human telomerase reverse transcriptase mRNA expression in the endometrium of patients with endometriosis
Hum. Reprod., March 1, 2007; 22(3): 843 - 849.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R Sato, C Maesawa, K Fujisawa, K Wada, K Oikawa, Y Takikawa, K Suzuki, H Oikawa, K Ishikawa, and T Masuda
Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis
Gut, July 1, 2004; 53(7): 1001 - 1009.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Zhou, P. A. Gehrig, Y. E. Whang, and J. F. Boggess
Rapamycin Inhibits Telomerase Activity by Decreasing the hTERT mRNA Level in Endometrial Cancer Cells
Mol. Cancer Ther., August 1, 2003; 2(8): 789 - 795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society